• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧乳腺癌:发病率与死亡率

Bilateral carcinoma of the breast: frequency and mortality.

作者信息

Mueller C B, Ames F

出版信息

Can J Surg. 1978 Sep;21(5):459-65.

PMID:719574
Abstract

Of 3558 women with cancer of the breast, 129 were found to have bilateral primary cancers. In approximately one quarter (33) of these women the two cancers developed synchronously; in the remainder (96) the second cancer developed metachronously, more than 6 months after the appearance of the first primary tumour. In two thirds (64) of the women in the latter group the second cancer made its appearance within 4 years after the first was detected. The 15-year survival curve for the 129 patients shows a 50% mortality at approximately 10 years, slightly better than that for the total group of 3558. At the time of our study (April 1975) 70 were alive and 59 were dead; 53 died as a result of their breast cancer and 6 from other causes. Only 3 of the 48 women in whom the first cancer developed before the age of 70 years died of causes other than breast cancer, giving a mortality due to breast cancer of 90%. The clinical stage, the recorded histopathology, the type of operation and the duration of time at risk after the first diagnosis did not differ significantly between those who lived and those who died. The authors conclude that age, stage or type of growth, operative therapy or time at risk do not determine the time of death or alter the 90% certainty that death will be due to carcinoma of the breast.

摘要

在3558例乳腺癌女性患者中,发现129例患有双侧原发性癌症。在这些女性患者中,约四分之一(33例)的双侧癌症是同时发生的;其余(96例)的第二处癌症是异时发生的,在第一处原发性肿瘤出现6个月以后。在后一组患者中,三分之二(64例)的第二处癌症在第一处被发现后的4年内出现。129例患者的15年生存曲线显示,大约在10年时死亡率为50%,略优于3558例患者的总体情况。在我们的研究期间(1975年4月),70例存活,59例死亡;53例死于乳腺癌,6例死于其他原因。在48例第一处癌症发生在70岁之前的女性患者中,只有3例死于乳腺癌以外的原因,乳腺癌导致的死亡率为90%。存活者和死亡者在临床分期、记录的组织病理学、手术类型以及首次诊断后的风险持续时间方面没有显著差异。作者得出结论,年龄、生长阶段或类型、手术治疗或风险持续时间并不能决定死亡时间,也不能改变死亡将由乳腺癌导致的90%的确定性。

相似文献

1
Bilateral carcinoma of the breast: frequency and mortality.双侧乳腺癌:发病率与死亡率
Can J Surg. 1978 Sep;21(5):459-65.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
[The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].[双侧乳腺癌与单侧乳腺肿瘤的预后比较。5年和10年随访]
Strahlenther Onkol. 1995 Apr;171(4):207-13.
4
Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.双侧乳腺癌:同时性和异时性疾病患者的危险因素及预后
Cancer. 2000 Jun 15;88(12):2739-50.
5
[Bilateral primary breast cancer: a report of 217 cases].[双侧原发性乳腺癌:217例报告]
Zhonghua Zhong Liu Za Zhi. 2004 Dec;26(12):756-8.
6
Prognostic factors in bilateral breast cancer.双侧乳腺癌的预后因素
Neoplasma. 1994;41(6):353-7.
7
[Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].[肺多原发性肿瘤合并其他器官的临床特征及预后——附281例报告]
Ai Zheng. 2006 Jun;25(6):731-5.
8
Bilateral primary breast cancers: a clinicopathological study of the second primary.双侧原发性乳腺癌:对第二原发性肿瘤的临床病理研究
Int Surg. 1996 Jan-Mar;81(1):57-60.
9
Causes of death among female patients with cancer of the breast and intestines.乳腺癌和肠癌女性患者的死因
Ann Clin Res. 1977 Feb;9(1):15-24.
10
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.1991年4月至1997年3月哥本哈根乳腺癌的乳腺X线筛查。乳腺X线筛查评估小组。
APMIS Suppl. 1998;83:1-44.

引用本文的文献

1
First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer.螺旋断层放射治疗同步整合加量用于双侧同步乳腺癌的首例临床报告
Br J Radiol. 2017 Aug;90(1077):20170152. doi: 10.1259/bjr.20170152. Epub 2017 Jul 14.
2
Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study.断层放射治疗在同步双侧乳腺癌治疗中的应用:剂量学比较研究。
Br J Radiol. 2015 Apr;88(1048):20140612. doi: 10.1259/bjr.20140612. Epub 2015 Jan 21.
3
Follow-up design of unexpected enhancing lesions on preoperative MRI of breast cancer patients.
乳腺癌患者术前MRI上意外强化病变的随访设计
Diagn Interv Radiol. 2015 Jan-Feb;21(1):16-21. doi: 10.5152/dir.2014.13471.
4
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.用于评估同步性单侧和双侧浸润性乳腺癌肿瘤对之间基因组相似性的基因芯片比较基因组杂交技术
BMC Clin Pathol. 2008 Jul 10;8:6. doi: 10.1186/1472-6890-8-6.
5
Prognostic significance of synchronous and metachronous bilateral breast cancer.同步性和异时性双侧乳腺癌的预后意义
World J Surg. 2001 Sep;25(9):1117-24. doi: 10.1007/BF03215857.
6
Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.乳腺癌的病理生物学:生物预定论与长期生存假说
Klin Wochenschr. 1981 Aug 3;59(15):819-29. doi: 10.1007/BF01721051.
7
How breast cancer presents.乳腺癌的表现方式。
Can Med Assoc J. 1983 Jul 1;129(1):43-7.
8
Adjuvant chemotherapy of breast cancer: hope--reality--hazard?乳腺癌辅助化疗:希望——现实——风险?
Klin Wochenschr. 1984 Feb 15;62(4):149-61. doi: 10.1007/BF01731637.
9
Second primary cancers of the breast: incidence and risk factors.乳腺第二原发性癌:发病率及危险因素
Br J Cancer. 1984 Jan;49(1):79-85. doi: 10.1038/bjc.1984.12.
10
Breast cancer.乳腺癌
Can Med Assoc J. 1983 Nov 1;129(9):913-4, 918, 920.